Hématomes cutanés et sous-cutanés vus en dermatologie : 17 cas

Estève, É.; Armingaud, P; Martin, Ludovic

doi:10.1016/s0151-9638(04)93667-8

Cited by 3 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some authors even suggest oral steroids such as prednisolone 0.5 mg/kg/day, slowly tapering over 4 weeks [13]. In case of ineffective treatment of the primary tumor, oral retinoids can be used to reduce hyperkeratosis [14]. There are encouraging results of PUVA therapy in the treatment of Bazex syndrome [15].…”

Section: Discussionmentioning

confidence: 99%

Acrokeratosis Paraneoplastica (Bazex Syndrome): A Case Report

et al. 2022

View full text Add to dashboard Cite

Acrokeratosis paraneoplastica Bazex is a rare paraneoplastic skin manifestation, typically causing acral psoriasiform lesions. Patients usually show erythematous hyperkeratosis with yellowish, adherent scales on the hands and feet or other acral locations such as ears or nose. We herein report a case of Bazex syndrome in a male patient, who was previously diagnosed with hepatocellular carcinoma. Our case report highlights this rare condition as early diagnosis may impact the patient’s course of tumor disease and prognosis.

show abstract